Announcements

  • Bezlotoxumab May Cut Recurrent C. Diff in IBD

    The human monoclonal antibody bezlotoxumab (Zinplava) appeared effective for treating recurrent Clostridium difficile infection (rCDI) in patients with inflammatory bowel disease (IBD), researchers said.
  • New Compounds Might Help Stop Spread of Malaria

    Malaria is transmitted by mosquitoes carrying malaria parasites, but scientists report they have discovered compounds that might keep mosquitoes from spreading the sometimes deadly disease.
  • New Study Prompts Updates To MDR-TB Treatment Guidelines

    The new research has led the World Health Organization to announce landmark changes in line with the study’s findings.
  • Can counseling, links to services cut death rates in half among people with HIV who inject drugs?

    A study across three countries where HIV incidence is fueled by substance use found that a little support went a long way for people living with the virus and injecting drugs — helping them to stay on antiretroviral treatment and opioid substitution therapy, and keep their viral levels suppressed.
  • Vaccines Against H.I.V., Malaria and Tuberculosis Unlikely, Study Says

    Vaccines against H.I.V., malaria and tuberculosis — three major killers of the world’s poor — are unlikely to be produced in the foreseeable future unless vastly more money is committed to finding them, a new study has concluded.
  • Yellow fever patient in Republic of Congo prompts outbreak declaration, response

    Republic of Congo health officials are calling risks to public health at a national level high, and at a regional level moderate, after confirmation that a man was infected with yellow fever in a city densely populated with about a million people, as well as with mosquitos capable of spreading the virus, according to a report from the World Health Organization today.
  • 'Predatory Bacteria' Might Be Enlisted In Defense Against Antibiotic Resistance

    Here's a bold idea to fight back against bacteria that can't be stopped by antibiotics: Go after them with germ-eating microbes.
  • Delamanid delay comes home

    A note from the field in this week’s Morbidity and Mortality Weekly Report describes the case of a dangerously ill man in the United States.
  • CDC Says Adults And Children Older Than Six Months Should Get Flu Vaccine By End Of October

    It’s technically still summer, but the Centers for Disease Control and Prevention (CDC) says it’s already time to think about flu season 2018-2019.
  • Why Haven’t We Cured The Common Cold Yet?

    Polio, smallpox, hepatitis A and B are all serious viruses humanity learned to subdue with effective solutions.
  • Nasal spray flu vaccine gets green light from CDC this year

    After advising the public to avoid the nasal spray version of the flu vaccine for the last two years, the Centers for Disease Control and Prevention is now giving it the green light.
  • As deadline approaches for HIV control testing and treatment targets, sex workers still face “glarin

    When, in the months leading up to the 2014 International AIDS Conference in Melbourne, a team of researchers put together a series of articles examining the drivers and impacts  HIV among sex workers, they found that missing data on incidence, care, treatment, and prevention services and missing efforts to address structural obstacles that included discriminatory policies, attitudes and laws were stalling the progress that could be made, and that had been made across the broader pandemic.
  • Ebola vaccinations could start Wednesday in Congo outbreak

    The deadly Ebola virus has killed at least nine people in Congo’s latest outbreak in North Kivu province, the country’s health ministry said Tuesday, while the World Health Organization said vaccinations could begin as early as Wednesday.
  • 1 in 7 babies exposed to Zika in U.S. territories have birth defects, nervous system problems

    The first look at how children exposed to Zika virus in the womb are faring at age 1 and older is out, and the report is sobering.
  • Increase in tick-borne diseases likely, US experts say

    As studies document the growing incidence of tick-borne disease in the United States, a new commentary in the New England Journal of Medicine (NEJM) says the public health burden of tick-borne pathogens is considerably underestimated.
  • New Ebola species is reported for first time in a decade

    The family of Ebola viruses has just gotten a bit bigger.
  • New Drug Wipes Out Malaria In A Single Dose — But There's One Hitch

    The world now has a potent, new weapon against malaria — one that can wipe out the parasite from a person's body with a single dose.
  • Laws meant to end demand for sex work increases workers’ HIV risks, researchers say

    Laws and policies that criminalize clients of sex workers rather than criminalizing sex workers themselves put sex workers at higher risk of HIV infection, researchers said here on Thursday.
  • Next-Gen HIV Vaccines Safe with Durable Immune Response

    HIV vaccine candidates yielded immune responses that lasted at least a year after the final shot, a researcher said here.
  • Opioid substitution therapy, outreach to sex workers rank among most cost effective HIV intervention

    Investments in opioid substitution therapy, outreach to sex workers, medical circumcision and condom promotion are the most cost-effective prevention interventions in the global HIV response, but lack adequate funding and should be scaled up to achieve prevention targets, researchers said here today.
  • Don’t panic if you’re put on a waiting list for the new shingles vaccine

    Ann Dieffenbach got her first shot of the new shingles vaccine, Shingrix, at her CVS pharmacy in Bethesda on Feb. 25.
  • Elton John announces HIV funding for LGBT and people who inject drugs in Eastern Europe, Central Asi

    Non-governmental organizations in eastern Europe and central Asia providing essential HIV treatment and prevention services to populations who have been left behind in the global HIV response will soon get an infusion of resources to reach people who inject drugs and lesbian, gay, bisexual and transgender communities.
  • Ebola Eludes Drug Testing Once More as Outbreak Tapers Off

    As the Ebola outbreak ebbs in central Africa, the lethal virus has once again evaded testing that’s crucial to developing a cure.
  • Report Warns Of 'Dangerous Complacency' In The Fight Against HIV

    In the early 2000s — the beginning of the third decade of the AIDS epidemic--the world came together in an unprecedented global health effort to provide life-saving AIDS drugs to people even in the poorest corners of the world.
  • Countries accused of failing to meet pledge to tackle antibiotic misuse

    Only half of 200 or so countries have abided by a pledge to tackle the use of antibiotics with concerted nationwide efforts, threatening lives and crops, particularly in poor countries, expert groups said on Wednesday.
  • UNAIDS global HIV data shows “miles to go”

    The tale of two global HIV responses continues to unfold this week, in data released by UNAIDS in the run-up to the 22nd International AIDS Conference in Amsterdam.
  • McDonald’s pulls salad from thousands of locations after people are sickened by parasite

    McDonald's has stopped selling salads at some 3,000 locations across the country amid a multi-state parasite outbreak that has sickened dozens of customers.
  • Drug to Treat Smallpox Approved by F.D.A., a Move Against Bioterrorism

    The Food and Drug Administration on Friday approved the first drug intended to treat smallpox — a move that could halt a lethal pandemic if the virus were to be released as a terrorist bioweapon or through a laboratory accident.
  • FDA Panel Backs Tafenoquine for 'Radical Cure' of Malaria

    An FDA advisory committee voted to recommend approval of single-dose tafenoquine (GlaxoSmithKline) in patients 16 and older for the "radical cure" (prevention of relapse) of malaria, finding both substantial evidence for efficacy and adequate evidence for safety.
  • 'Citizen scientists' take on growing threat of tick-borne diseases

    In May, the Centers for Disease Control and Prevention said cases of tick-borne diseases, such as Lyme disease, have been exploding across the U.S.
  • Scientists Find New Tricks For Old Drugs

    Most drugs have side effects, but sometimes they're actually good news.
  • State Prisons Fail To Offer Cure To 144,000 Inmates With Deadly Hepatitis C

    State prisons across the U.S. are failing to treat at least 144,000 inmates who have hepatitis C, a curable but potentially fatal liver disease, according to a recent survey and subsequent interviews of state corrections departments.
  • Explaining 'herd immunity' may convince more people to get flu shots

    The knowledge that getting a flu shot can help prevent flu from spreading in the community may help convince more people to get vaccinated, a U.S. study suggests.
  • In Lesotho, where life expectancy is under 50, the last to test for HIV are the hardest to reach

    Clinics for men, adolescent-dedicated sections in existing clinics, and increased support for community-based services are all needed to expand the reach of HIV testing in Lesotho, and offer hope of controlling the epidemic in a country where the virus is responsible for one of the shortest life expectancies in the world, according to a report released Thursday by the U.S. Centers for Disease Control and Prevention.
  • Proof of Children’s Vaccinations? Italy Will Now Take Parents’ Word for It

    Italian parents will no longer have to provide state-run schools with a doctor’s note to show that their children have been vaccinated, the country’s new populist government announced on Thursday — a move that raised alarm among experts who fear that compliance with vaccines will drop.
  • Species-specific activity of antibacterial drug combinations

    The spread of antimicrobial resistance has become a serious public health concern, making once-treatable diseases deadly again and undermining the achievements of modern medicine.
  • Bacterial disease deaths in Puerto Rico hit 'epidemic' level after Hurricane Maria: report

    After Hurricane Maria, Puerto Rico saw a spike in deaths from a bacterial disease to the point that it should have been labeled an "epidemic," according to medical experts who analyzed previously unreleased data for CNN.
  • First clinical MERS vaccine by Inovio and GeneOne shows promise

    Inovio and GeneOne Life Science’s MERS vaccine, which is receiving financial support from the International Vaccine Institute (IVI) and the Coalition for Epidemic Preparedness Innovations (CEPI), elicited high levels of antibodies and T-cell responses in a phase 1 study.
  • High-Resolution Snapshot of Zika Virus Reveals Clues to Fighting It

    Scientists have captured the clearest and most detailed image yet of Zika, the virus that set off a global health crisis in 2015 and 2016 and left thousands of babies with serious birth defects.